Leafy Tunnel
Venture capitalLondon · Seed–Series A · 2 people tracked
Find your way into Leafy Tunnel
28 people in our graph share verified history with the Leafy Tunnel team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Leafy Tunnel focuses on backing companies developing alternative medicines aimed at addressing mental health issues and pain-related disorders. Its stated investment interest centers on therapeutic approaches in these areas.
Source: firm website, verified Aug 3, 2026.
Team · 2 people
from the firm's website
What they invest in
from 10 of 10 portfolio companiesBiotech ×7Digital Health ×4Healthtech ×4Medical Devices ×4Mental Health ×4Deep Tech ×3AI & Machine Learning ×2AgTech ×1
HQs:Canada×1Denmark×1United Kingdom×1United States×1
Investments · 10 tracked
founders shown can be your intro path
AtaiBeckley develops rapid-acting mental health treatments and therapies for patients with difficult-to-treat mental health conditions.
BiotechDeep TechDigital HealthMedical DevicesMental Health
Srinivas Rao(Co-Founder and Chief Executive Officer)inChristian Angermayer(Founder and Chairman of the Board)
Co-investorsAble PartnersAlpha Wave GlobalCatalio Capital Management, LPFJ LabsFuture VenturesNucleus Adventure Capital+3 more
AtaiBeckley develops rapid-acting and durable mental health treatments for patients with difficult-to-treat mental health conditions.
BiotechMedical DevicesMental Health
Christian AngermayerCosmo Feilding Mellen(Founder)inSrinivas Rao
Co-investorsFJ LabsIter InvestmentsNoeticRedbus VenturesWhat If Ventures
Ceretype develops brain imaging and analysis tools that provide insights into brain circuitry for therapeutic development and clinical care of psychiatric and neurological disorders.
AI & Machine LearningBiotechDigital HealthMedical Devices
Emily Stern(CEO)inRoni Setton(Scientific Director)in
BoardDavid Silbersweig(SAB Chair)
Co-investorsJLS
BiotechHealthtechCambridge, US
Emily Stern(Executive Officer, Director)Hong Pan(Director)
BoardDavid Silbersweig(Director)Richard Lipkin(Director)
IUVO is a cannabis company that partners with craft cultivators, including Organnicraft, a British Columbia-based grower of premium cannabis strains from the legacy markets of California and BC.
AgTechConsumer
Lycos PBC develops investigational psychedelic-based therapeutics to treat mental health conditions, with an initial focus on post-traumatic stress disorder.
BiotechDeep TechMental Health
Co-investorsJourneyOne VenturesLauder PartnersSolari CapitalWGD Capital, L.P.XEIA Venture Partners
Maya Health (Naitur) builds compliance-focused AI automation for independent health and wellness practices, covering intake-to-EMR sync, follow-ups, lab result delivery, rating-scale scoring, and safety escalation.
AI & Machine LearningDigital HealthHealthtech
Co-investorsInnovating CapitalPsyMed Ventures
Prohibition Partners operates a B2B discovery platform and ecosystem for the legal cannabis industry, offering conferences, market intelligence content, digital media publishing, and a marketplace for cannabis businesses to transact products and services.
B2B MarketplacesCrypto & Web3Data & InfrastructureFintechMedia & EntertainmentLondon, GB
Stephen Murphy(Founder)in
Tactogen develops patented new chemical entities, including benzofuran-based compositions, and conducts preclinical research and publishes data on these compounds.
BiotechDeep TechHealthtech
Matthew Baggott(CEO)in
Co-investorsNoeticPsyMed Ventures
Tetra Pharm develops next-generation drugs targeting neurological disorders including chronic pain, Alzheimer's, and obesity.
BiotechDigital HealthHealthtechMedical DevicesMental HealthCopenhagen, DK
Exits · 1
IPOs and acquisitions across the tracked portfolioAtaiBeckleyNASDAQ: ATAI
Portfolio news
latest coverage across their companiesAtaiBeckley · investing.com · Jul 17, 2026
Beckley Psytech · wmbdradio.com · Jul 16, 2026
Principals & officers · per Companies House
what is this? ⓘNikolay Tretiyakov — 75–100% of shares, 75–100% of voting rights, right to appoint and remove directors
Frequently asked questions
- How many investments has Leafy Tunnel made?
- Leafy Tunnel has 9 tracked investments.
- What stage does Leafy Tunnel invest at?
- Leafy Tunnel invests at the Seed, Series A stages.
- What sectors does Leafy Tunnel focus on?
- Leafy Tunnel focuses on Biotech, Healthtech, Medical Devices, Mental Health, Wellness & Fitness.
- Where is Leafy Tunnel located?
- Leafy Tunnel is headquartered in London, GB.
- Who does Leafy Tunnel co-invest with?
- Leafy Tunnel most often shares deals with FJ Labs, Noetic, PsyMed Ventures, among 21 tracked co-investors.
Media · Podcasts & interviews
featuring the teamProfessionally Cannabis | Bek Muslimov & Nikolay Tretiyakov, Co-Founders of Leafy Tunnel | EP62
Global Cannabis Intelligence · Nikolay Tretiyakov
Similar investors
JAZZ Venture Partners is a venture capital firm investing in companies at the intersection of technology, neuroscience, and human performance, spanning digital health, biosciences, and AI.
HealthQuad is a healthcare-focused investment firm that partners with entrepreneurs building category-defining healthcare businesses, leveraging its healthcare network and clinical/operating expertise.
LongeVC is a venture capital firm backing early-stage founders in biotech and longevity, aiming to bring breakthrough science and treatments to market.
Foreground Capital is a venture capital firm dedicated to investing in the future of women's health, building on its predecessor track record at RH Capital.
Next Ventures is an investment firm that backs founders building solutions to improve health care access and enhance human capability.